In this video we will learn about:
1. FDA's Coronavirus treatment acceleration program.
2. Dr.Fauci's changed stance on public use of masks.
3. Approval of Remdesivir as COVID-19 treatment on the basis of reduction of hospital stay.
4. Pharmacokinetic and Phramacodynamic considerations of Remdesivir
5. Discussion about study design and results of Remdesivir clinical trials.
6. Safety concerns and adverse reactions of Remdesivir treatment.
Presented by Dr. Mobeen Syed
Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.